Ascertain Secures $10 Million for AI-Driven Case Management Platform
Ascertain secures $10 million for its AI-driven case management platform, aiming to reduce administrative burdens in healthcare. 💰🤖
Advancements in artificial intelligence for the diagnosis and management of anterior segment diseases.
AI in anterior segment disease diagnosis shows 90% accuracy, enhancing personalized care and treatment outcomes. 🤖👁️
Woebot Health to Retire AI Mental Health App
Woebot Health will retire its AI mental health app on June 30. Users can download conversation history until then. 📅💬
Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience).
Patient experiences with intranasal esketamine show 88.4% report improved quality of life in treatment-resistant depression. 🌟🧠
Eli Lilly Takes Legal Action Against Telehealth Companies for Selling Unapproved Drugs
Eli Lilly has filed lawsuits against telehealth companies for selling unapproved drugs containing tirzepatide, risking patient safety. ⚖️💊
Expert and Interdisciplinary Analysis of AI-Driven Chatbots for Mental Health Support: Mixed Methods Study.
AI Chatbots in Mental Health: Risks, Trust Issues, and Ethical Concerns 🤖🧠
HeartBeam and AccurKardia Collaborate to Enhance Cardiac Diagnostics
HeartBeam and AccurKardia collaborate to improve cardiac diagnostics with advanced ECG analysis software. 📈❤️
When the whole is greater than the sum of its parts: why machine learning and conventional statistics are complementary for predicting future health outcomes.
Machine learning 🤖 and conventional statistics 📊 enhance health outcome predictions together, as shown in recent research.